China National Medicines Corporation Ltd.’s Net Profit Rose 10.4% in 2022

China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (600511.SH) reported a net profit of 2.1 billion yuan in 2022, up 10.4% year-on-year.

Meanwhile, the company posted 45.5 billion yuan in revenue, down 2.1% year-on-year.

At the end of the reporting period, it had 29.6 billion yuan in total assets and 13.7 billion yuan in total liabilities, with a liability-to-asset ratio of 46.4%.